Celiac disease

Alberto Rubio-Tapia, Joseph A Murray

Research output: Contribution to journalArticle

117 Citations (Scopus)

Abstract

Purpose of review: To summarize recent advances in celiac disease published between August 2008 and July 2009. Recent findings: Celiac disease affects nearly 1% of most populations but remains largely unrecognized. In the last year, work has shown that the prevalence of celiac disease has increased dramatically, not simply due to increased detection. Also, undiagnosed celiac disease may be associated with increased mortality. Significant progress has been made in understanding how gliadin peptides can cross the intestinal border and access the immune system. New genetic loci and candidate genes that may contribute to the risk of celiac disease and its overlap with type 1 diabetes mellitus have been identified. Novel deamidated gliadin peptides antibodies have better diagnostic accuracy over native gliadin-based tests. The inclusion of duodenal bulb biopsy specimens may increase the rate of celiac disease detection. The spectrum of celiac disease likely includes a minority of patients with mild enteropathy. A practical seven-item instrument may facilitate standardized evaluation of gluten-free diet adherence. Finally, refractory celiac disease, although rare, is associated with a poor prognosis. Summary: Celiac disease is a global health problem that requires a multidisciplinary and increasingly cooperative multinational research effort.

Original languageEnglish (US)
Pages (from-to)116-122
Number of pages7
JournalCurrent Opinion in Gastroenterology
Volume26
Issue number2
DOIs
StatePublished - Mar 2010

Fingerprint

Celiac Disease
Gliadin
Gluten-Free Diet
Peptides
Genetic Loci
Type 1 Diabetes Mellitus
Immune System
Biopsy
Mortality
Antibodies
Research

Keywords

  • Autoimmunity
  • Gluten
  • Mortality
  • Undiagnosed celiac disease

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Celiac disease. / Rubio-Tapia, Alberto; Murray, Joseph A.

In: Current Opinion in Gastroenterology, Vol. 26, No. 2, 03.2010, p. 116-122.

Research output: Contribution to journalArticle

Rubio-Tapia, Alberto ; Murray, Joseph A. / Celiac disease. In: Current Opinion in Gastroenterology. 2010 ; Vol. 26, No. 2. pp. 116-122.
@article{64837753a5d84363af1cde7b73b6f2b5,
title = "Celiac disease",
abstract = "Purpose of review: To summarize recent advances in celiac disease published between August 2008 and July 2009. Recent findings: Celiac disease affects nearly 1{\%} of most populations but remains largely unrecognized. In the last year, work has shown that the prevalence of celiac disease has increased dramatically, not simply due to increased detection. Also, undiagnosed celiac disease may be associated with increased mortality. Significant progress has been made in understanding how gliadin peptides can cross the intestinal border and access the immune system. New genetic loci and candidate genes that may contribute to the risk of celiac disease and its overlap with type 1 diabetes mellitus have been identified. Novel deamidated gliadin peptides antibodies have better diagnostic accuracy over native gliadin-based tests. The inclusion of duodenal bulb biopsy specimens may increase the rate of celiac disease detection. The spectrum of celiac disease likely includes a minority of patients with mild enteropathy. A practical seven-item instrument may facilitate standardized evaluation of gluten-free diet adherence. Finally, refractory celiac disease, although rare, is associated with a poor prognosis. Summary: Celiac disease is a global health problem that requires a multidisciplinary and increasingly cooperative multinational research effort.",
keywords = "Autoimmunity, Gluten, Mortality, Undiagnosed celiac disease",
author = "Alberto Rubio-Tapia and Murray, {Joseph A}",
year = "2010",
month = "3",
doi = "10.1097/MOG.0b013e3283365263",
language = "English (US)",
volume = "26",
pages = "116--122",
journal = "Current Opinion in Gastroenterology",
issn = "0267-1379",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Celiac disease

AU - Rubio-Tapia, Alberto

AU - Murray, Joseph A

PY - 2010/3

Y1 - 2010/3

N2 - Purpose of review: To summarize recent advances in celiac disease published between August 2008 and July 2009. Recent findings: Celiac disease affects nearly 1% of most populations but remains largely unrecognized. In the last year, work has shown that the prevalence of celiac disease has increased dramatically, not simply due to increased detection. Also, undiagnosed celiac disease may be associated with increased mortality. Significant progress has been made in understanding how gliadin peptides can cross the intestinal border and access the immune system. New genetic loci and candidate genes that may contribute to the risk of celiac disease and its overlap with type 1 diabetes mellitus have been identified. Novel deamidated gliadin peptides antibodies have better diagnostic accuracy over native gliadin-based tests. The inclusion of duodenal bulb biopsy specimens may increase the rate of celiac disease detection. The spectrum of celiac disease likely includes a minority of patients with mild enteropathy. A practical seven-item instrument may facilitate standardized evaluation of gluten-free diet adherence. Finally, refractory celiac disease, although rare, is associated with a poor prognosis. Summary: Celiac disease is a global health problem that requires a multidisciplinary and increasingly cooperative multinational research effort.

AB - Purpose of review: To summarize recent advances in celiac disease published between August 2008 and July 2009. Recent findings: Celiac disease affects nearly 1% of most populations but remains largely unrecognized. In the last year, work has shown that the prevalence of celiac disease has increased dramatically, not simply due to increased detection. Also, undiagnosed celiac disease may be associated with increased mortality. Significant progress has been made in understanding how gliadin peptides can cross the intestinal border and access the immune system. New genetic loci and candidate genes that may contribute to the risk of celiac disease and its overlap with type 1 diabetes mellitus have been identified. Novel deamidated gliadin peptides antibodies have better diagnostic accuracy over native gliadin-based tests. The inclusion of duodenal bulb biopsy specimens may increase the rate of celiac disease detection. The spectrum of celiac disease likely includes a minority of patients with mild enteropathy. A practical seven-item instrument may facilitate standardized evaluation of gluten-free diet adherence. Finally, refractory celiac disease, although rare, is associated with a poor prognosis. Summary: Celiac disease is a global health problem that requires a multidisciplinary and increasingly cooperative multinational research effort.

KW - Autoimmunity

KW - Gluten

KW - Mortality

KW - Undiagnosed celiac disease

UR - http://www.scopus.com/inward/record.url?scp=77149132464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77149132464&partnerID=8YFLogxK

U2 - 10.1097/MOG.0b013e3283365263

DO - 10.1097/MOG.0b013e3283365263

M3 - Article

C2 - 20040864

AN - SCOPUS:77149132464

VL - 26

SP - 116

EP - 122

JO - Current Opinion in Gastroenterology

JF - Current Opinion in Gastroenterology

SN - 0267-1379

IS - 2

ER -